148 assets in Amyotrophic Lateral Sclerosis

Therapeutic assets addressing Amyotrophic Lateral Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Taurursodiol Amyotrophic Lateral Sclerosis	Amylyx Pharmaceuticals Inc.	P3	BBB (74)
Tofersen Amyotrophic Lateral Sclerosis	Biogen	P4	BBB (72)
Riluzole Amyotrophic Lateral Sclerosis	AB Science	P4	BB (69)
Autologous Mesenchymal Stromal Cells Secreting Neurotrophic Factors Amyotrophic Lateral Sclerosis	Brainstorm-Cell Therapeutics	P3	BB (66)
mt-1186 Amyotrophic Lateral Sclerosis	Tanabe Pharma Corporation	P3	BB (66)
L-Carnitine Amyotrophic Lateral Sclerosis	ChaodongWang	P4	BB (65)
Ibudilast Amyotrophic Lateral Sclerosis	MediciNova	P2/3	BB (64)
Lenzumestrocel Amyotrophic Lateral Sclerosis	Corestemchemon, Inc.	P3	B (62)
Pridopidine Amyotrophic Lateral Sclerosis	Prilenia	P3	B (62)
Lithium, Elemental Amyotrophic Lateral Sclerosis	Stichting TRICALS Foundation	P3	B (61)
Masitinib Amyotrophic Lateral Sclerosis	AB Science	P3	B (61)
Cnm-Au8 Amyotrophic Lateral Sclerosis	Clene Nanomedicine	P2/3	B (60)
dnl343 Amyotrophic Lateral Sclerosis	Merit E. Cudkowicz, MD	P2/3	B (60)
Tacrolimus Amyotrophic Lateral Sclerosis	University of Edinburgh	P2/3	B (60)
Dolutegravir Amyotrophic Lateral Sclerosis	Macquarie University, Australia	P3	B (59)
ap-101 Amyotrophic Lateral Sclerosis	Université de Sherbrooke	P2	B (58)
Fhnd1002 Amyotrophic Lateral Sclerosis	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.	P2	B (58)
rns60 Amyotrophic Lateral Sclerosis	Revalesio Corporation	P2	B (58)
Teonanacatl Amyotrophic Lateral Sclerosis	University Medical Center Groningen	P2	B (58)
Amantadine Amyotrophic Lateral Sclerosis	University of Edinburgh	P2/3	B (57)
Astaxanthine Amyotrophic Lateral Sclerosis	Duke University	P2	B (57)
Engensis Amyotrophic Lateral Sclerosis	Helixmith Co., Ltd.	P2	B (57)
Melatonin Amyotrophic Lateral Sclerosis	Duke University	P2	B (57)
Memantine Hydrochloride Amyotrophic Lateral Sclerosis	University of Edinburgh	P2/3	B (57)
Mitoquinol Mesilate Amyotrophic Lateral Sclerosis	Duke University	P2	B (57)
Protandim Amyotrophic Lateral Sclerosis	Duke University	P2	B (57)
Ranolazine Amyotrophic Lateral Sclerosis	Swathy Chandrashekhar, MBBS	P2	B (57)
Trazodone Hydrochloride Amyotrophic Lateral Sclerosis	University of Edinburgh	P2/3	B (57)
Treg Cells Amyotrophic Lateral Sclerosis	The Methodist Hospital Research Institute	P2	B (56)
cb03-154 Amyotrophic Lateral Sclerosis	Shanghai Zhimeng Biopharma, Inc.	P2/3	CCC (55)
Fosigotifator Sodium Tromethamine Amyotrophic Lateral Sclerosis	Merit E. Cudkowicz, MD	P2/3	CCC (55)
Galunisertib Amyotrophic Lateral Sclerosis	Gipfel Life Sciences GmbH	P2/3	CCC (55)
Nerandomilast Amyotrophic Lateral Sclerosis	Gipfel Life Sciences GmbH	P2/3	CCC (55)
Tazbentetol Amyotrophic Lateral Sclerosis	Spinogenix	P2/3	CCC (55)
Verdiperstat Amyotrophic Lateral Sclerosis	Merit E. Cudkowicz, MD	P2/3	CCC (55)
Zilucoplan Amyotrophic Lateral Sclerosis	Merit E. Cudkowicz, MD	P2/3	CCC (55)
3K3A-APC Amyotrophic Lateral Sclerosis	Macquarie University, Australia	P2	CCC (54)
Abacavir Amyotrophic Lateral Sclerosis	Macquarie University, Australia	P3	CCC (54)
Abatacept Recombinant Amyotrophic Lateral Sclerosis	Massachusetts General Hospital	P1/2	CCC (54)
fab122 Amyotrophic Lateral Sclerosis	Ferrer Internacional S.A.	P3	CCC (54)
ion363 Amyotrophic Lateral Sclerosis	Ionis Pharmaceuticals, Inc.	P3	CCC (54)
Lam-002A Amyotrophic Lateral Sclerosis	OrphAI Therapeutics	P2	CCC (54)
Lamivudine Amyotrophic Lateral Sclerosis	Macquarie University, Australia	P3	CCC (54)
N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE Amyotrophic Lateral Sclerosis	Woolsey Pharmaceuticals	P2	CCC (54)
Nivestim Amyotrophic Lateral Sclerosis	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (54)
Oditrasertib Amyotrophic Lateral Sclerosis	Sanofi	P2	CCC (54)
Sephin 1 Amyotrophic Lateral Sclerosis	InFlectis BioScience	P2	CCC (54)
Sls-005 Amyotrophic Lateral Sclerosis	Merit E. Cudkowicz, MD	P2/3	CCC (54)
spg302 Amyotrophic Lateral Sclerosis	Spinogenix	P2	CCC (54)
Tpn-101 Amyotrophic Lateral Sclerosis	Transposon Therapeutics, Inc.	P2	CCC (54)

Showing 1 to 50 of 148 assets

PreviousPage 1 of 3Next